Liangxian Cao,Thomas W. Davis,Samit Hirawat,Harry H. Miao,Langdon Miller,Charles M. Romfo,Marla L. Weetall
申请号：
US13321271
公开号：
US20120202801A1
申请日:
2010.05.27
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Methods for treating breast cancer involving the administration of a compound that selectively inhibits pathological production of human vascular endothelial growth factor (VEGF) are described. The compound can be administered as a single agent therapy or in combination with one or more additional therapies to a human in need of such treatment.
